You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fotemustine

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary CNS Lymphoma (PCNSL) Trial in Zhengzhou (HD-MTX-Ara-C regimen, FTD regimen)

Completed
  • Primary CNS Lymphoma (PCNSL)
  • HD-MTX-Ara-C regimen
  • FTD regimen
  • Zhengzhou, Henan, China
    Oncology Department of The First Affiliated Hospital of Zhengzho
Mar 2, 2022

Malignant Melanoma, Recurrent Melanoma Trial (Dacarbazine, Fotemustine, Interferon Alfa-2b)

Completed
Has Results
  • Malignant Melanoma
  • Recurrent Melanoma
  • (no location specified)
Oct 18, 2020

Primary CNS Lymphoma Trial in Zhengzhou (the dose-escalation phase)

Recruiting
  • Primary Central Nervous System Lymphoma
  • the dose-escalation phase
  • Zhengzhou, Henan, China
    Oncology Department of The First Affiliated Hospital of Zhengzho
May 30, 2022

Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Tumors Germ Cell and Embryonal Tumors by Histologic Type Tumors Tumors

Not yet recruiting
  • Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms
  • HX008 + TACE
  • +2 more
  • Beijing, Beijing, China
    Beijing Cancer hospital
Dec 8, 2022

Primary CNS Lymphoma Trial in Zhengzhou (rituximab in combination with methotrexate, cytarabine and dexamethasone)

Recruiting
  • Primary Central Nervous System Lymphoma
  • rituximab in combination with methotrexate, cytarabine and dexamethasone
  • Zhengzhou, Henan, China
    Oncology Department of The First Affiliated Hospital of Zhengzho
Sep 5, 2019

Malignant Melanoma Trial in Italy (bevacizumab [Avastin], fotemustine)

Completed
Has Results
  • Malignant Melanoma
  • bevacizumab [Avastin]
  • fotemustine
  • Firenze, Italy
  • +3 more
Nov 7, 2018

Relapsed Follicular Lymphoma Trial in Italy (ZEVALIN, BEAM)

Active, not recruiting
  • Relapsed Follicular Lymphoma
  • Genova, GE, Italy
  • +37 more
Dec 22, 2022

Uveal Melanoma Trial in Spain (ipilimumab, Nivolumab)

Completed
  • Uveal Melanoma
  • Palma De Mallorca, Baleares, Spain
  • +9 more
Mar 8, 2022

Glioblastoma Multiforme Trial in Milan, Rome (Temferon)

Recruiting
  • Glioblastoma Multiforme
  • Milan, Italy
  • +2 more
Feb 8, 2021

Melanoma, Brain Metastases Trial in Australia (Nivolumab, Ipilimumab)

Active, not recruiting
  • Melanoma
  • Brain Metastases
  • North Sydney, New South Wales, Australia
  • +3 more
Jun 8, 2021

Hydroxychloroquine, BRAF and MEK Inhibitors in Metastatic

Completed
  • Dermatology and Oncology
  • pre-treatment data
  • during study treatment
  • Pierre-Bénite, France
    Centre Hospitalier Lyon Sud
Feb 16, 2021

Melanoma Trial in Spain (vemurafenib and cobimetinib)

Completed
  • Melanoma
  • vemurafenib and cobimetinib
  • Donostia - San Sebastián, Guipuzcoa, Spain
  • +17 more
Feb 14, 2020

Glioblastoma Multiforme Trial in Italy (bevacizumab [Avastin], fotemustine)

Completed
Has Results
  • Glioblastoma Multiforme
  • bevacizumab [Avastin]
  • fotemustine
  • Napoli, Campania, Italy
  • +9 more
Feb 16, 2016

Malignant Melanoma Stage IV Trial in Genova, Napoli (Fotemustine + Vemurafenib)

Completed
  • Malignant Melanoma Stage IV
  • Fotemustine + Vemurafenib
  • Genova, Italy
  • +1 more
Jan 19, 2016

Uveal Melanoma Trial in France, Switzerland (Adjuvant chemo by Fotemustin, Intensive surveillance)

Unknown status
  • Uveal Melanoma
  • Adjuvant chemotherapy by Fotemustin
  • Intensive surveillance
  • Clermont-ferrand, France
  • +5 more
Apr 27, 2017

Brain Metastases Trial in Italy (Fotemustine, Fotemustine and Ipilimumab, Ipilimumab and nivolumab)

Unknown status
  • Brain Metastases
  • Fotemustine
  • +2 more
  • Bari, Italy
  • +10 more
Jun 1, 2015

Metastatic Malignant Melanoma Trial in Italy (Ipilimumab and Fotemustine)

Completed
  • Metastatic Malignant Melanoma
  • Ipilimumab and Fotemustine
  • Genoa, Italy
  • +6 more
May 12, 2015

Metastatic Melanoma Trial in Nice (blood test)

Unknown status
  • Metastatic Melanoma
  • blood test
  • Nice, France
    CHU de Nice ^Hôpital de l'Archet
Mar 21, 2016

Primary CNS Lymphoma (PCNSL) Trial in Zhengzhou (HD-MTX-Ara-C regimen, FVD regimen)

Unknown status
  • Primary CNS Lymphoma (PCNSL)
  • HD-MTX-Ara-C regimen
  • FVD regimen
  • Zhengzhou, Henan, China
    Oncology Department of The First Affiliated Hospital of Zhengzho
Jul 19, 2015

Uveal Melanoma Trial in Berlin, Erlangen, Essen (Placebo, Sorafenib)

Unknown status
  • Uveal Melanoma
  • Berlin, Germany
  • +2 more
Dec 2, 2014

Intraocular Melanoma, Metastatic Cancer Trial in Worldwide (fotemustine, isolated perfusion)

Terminated
  • Intraocular Melanoma
  • Metastatic Cancer
  • fotemustine
  • isolated perfusion
  • Milan, Italy
  • +7 more
Sep 20, 2012

Melanoma Trial run by the NCI (Laparotomy)

Completed
  • Melanoma
  • Laparotomy
  • Bethesda, Maryland
    National Cancer Institute (NCI)
Aug 17, 2012

Melanoma (Skin) Trial in Montpellier (fotemustine, gene expression analysis, polymerase chain reaction)

Completed
  • Melanoma (Skin)
  • fotemustine
  • +2 more
  • Montpellier, France
    Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
May 13, 2011